Ken E. Freeman

Plus aucun poste en cours

Profil

Dr. Kenneth E.
Freeman is Vice President at New Hill Management LLC.
Prior to joining New Hill Management LLC as Vice Prresident, he co-founded and served as Vice Chairman of the Supervisory Board of NADAG, a biotech company in Germany (MIT spinout), was Senior Director Financial Operations and a Member of the Board of Directors of ThromboGenics Ltd. (spinout Katholieke Universiteit Leuven), and has served as CFO and Vice President Corporate Development for Pepscan (spinout IDO-Lelystad).
Mr. Freeman was a Consultant at UCL Biomedica and has extensive experience as a consultant in a variety of technology oriented industries, was a member of the Board of Directors of the Irish Biotech Industry Association, and served as a Senior Analyst at the US Congressional Office of Technology Assessment.
He has been a Case Writer for London Business School and INSEAD and designed and conducted Business Planning Workshops at Flanders Business School, been a Visiting Scholar at CIS, MIT, a Professor at the US Naval War College, an Associate Fellow at the Royal United Services for Defence Studies, London and has played an active role in fostering entrepreneurship in Europe.
Mr. Freeman has a BA, magna cum laude, in International Relations from Eisenhower College, an MBA from Harvard Business School, a two year MPA from the J.F.
Kennedy School of Government, Harvard, and a Ph.D.
from King's College London.

Anciens postes connus de Ken E. Freeman

Sociétés	Poste	Fin
OXURION NV	Directeur/Membre du Conseil	-
UCL, Inc.	Corporate Officer/Principal	-
New Hill Management LLC	Directeur de la Recherche - Actions	-